Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Oliviero James F III
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Checkpoint Therapeutics, Inc.
Keryx Biopharmaceuticals Inc.
Nuvectis Pharma, Inc.
Keryx Biopharmaceuticals Inc.
Chief Financial Officer
Avg. Two Year Performance
1057%
Avg. Purchase Return
240%
Compound
55%
Avg. Sale Return
24%
Compound
Holdings:
209.41K
shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Drug Manufacturers - Major
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions
